Safety, Tolerability, Pharmacokinetics (PK), and Primary Clinical Efficacy of LY01616 in Patients With Advanced Solid Tumors
Clinical trial NCT05865925 · UNKNOWN
Trial details
- NCT number
- NCT05865925
- Sponsor
- Luye Pharma Group Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-22
- Primary completion
- 2024-08-31
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.